FEBRUARY 2010
26 February 2010 – Half Year Results - December 2009
24 February 2010 – Patrys Granted Key Patent
JANUARY 2010
28 January 2010 – Patrys – CSL Collaboration
NOVEMBER 2009
27 November 2009 – CEO’s Presentation to AGM 2009
11 November 2009 – Patrys Awarded Grant for Clinical Candidate PAT-SM6
OCTOBER 2009
27 October 2009 – Notice of 2009 Annual General Meeting
27 October 2009 – CEO Presentation at AusBiotech Life Sciences Investment Summit
6 October 2009 – Patrys Acquires Human Product SC1
SEPTMEBER 2009
22 September 2009 – CEO Investor Presentation
16 September 2009 – PAT-SM6 Prevents Colon Cancer Metastases
AUGUST 2009
28 August 2009 – Annual Report
24 August 2009 – Preclinical Development of PAT-SM6 and PAT-LM1 Finalised
17 August 2009 – Rights Issue $5 million raised
JULY 2009
10 July 2009 – Rights Issue Offer Documentation Mailed to Shareholders
10 July 2009 – Rights Issue Offer Documents
1 July 2009 – Shareholder Teleconference & Webcast Presentation
JUNE 2009
30 June 2009 – Patrys update via Teleconference & Webcast
29 June 2009 –Patrys announces $6.8 million rights issue
29 June 2009 –Appendix 3B – Rights Issue
29 June 2009 – Shareholder Letter & Notice of EGM
29 June 2009 – Update on Key Activities
29 June 2009 – Cleansing Statement
15 June 2009 – Successful Safety Studies for Lead Products PAT-LM1
and PAT-SM6
MAY 2009
25 May 2009 - Patrys commences safety studies for two lead products
FEBRUARY 2009
27 February 2009 - Patrys Presents at Scientific Conferences
25 February 2009 - Half Year Results – December 2008
DECEMBER 2008
23 December 2008 - Appointment of Company Secretary
15 December 2008 - Patrys-Challenge Fundraiser
5 December 2008 - Appendix 3Y - Change of Director's Interest Notice
4 December 2008 - Appendix 3Y - Change of Director's Interest Notice
4 December 2008 - Appendix 3Y - Change of Director's Interest Notice
4 December 2008 - Appendix 3Y - Change of Director's Interest Notice
3 December 2008 - Patrys Completes Acquisition of Technologies and US$2million
3 December 2008 - Manufacturer Wuxi AppTec Announces Rationalisation Plan
NOVEMBER 2008
28 November 2008 - Results of Annual General Meeting
28 November 2008 – Appendix 3B
27 November 2008 - Chairman’s address to shareholders
27 November 2008 - CEO’s presentation to AGM
13 November 2008 - Five Patrys lead products demonstrate therapeutic potential
OCTOBER 2008
30 October 2008 – Appendix 4C Quarterly
29 October 2008 – Patrys Ltd to acquire assets of Acceptys, Inc
29 October 2008 – Notice of Annual General Meeting and Final Annual Report
SEPTEMBER 2008
30 September 2008 – Annual Report
AUGUST 2008
29 August 2008 – Appendix 4E Preliminary Financial Report
JULY 2008
31 July 2008 – Appendix 4C quarterly
31 July 2008 – CEO presentation at 6th Annual Australian Biotechnology Summit
9 July 2008 - Becoming a substantial shareholder of PAB
JUNE 2008
30 June 2008 - Release of Securities from Escrow
23 June 2008 - Online Newsletter
APRIL 2008
24 April 2008 - Appendix 4C quarterly
24 April 2008 - Release of Options from Escrow
21 April 2008 - CEO presentation at Excellence in Biotechnology Investment
09 April 2008 - CEO presentation – Lodge Mid Cap Confab
07 April 2008 - Patrys Ltd CEO on Strategy and Outlook update
03 April 2008 - Trading volume update
MARCH 2008
28 March 2008 - Becoming a substantial holder for PAB
FEBRUARY 2008
28 February 2008 - Appendix 4D and Half Yearly Report
08 February 2008 - Becoming a substantial shareholder
JANUARY 2008
31 January 2008 - Commencement of Scale-up Manufacturing of Lead Product
31 January 2008 - Acceptys and Seattle Biomedical Research Institute Join in Fight Against Malaria
31 January 2008 - Appendix 4C quarterly
14 January 2008 - Release from escrow
DECEMBER 2007
14 December 2007 - Online newsletter
NOVEMBER 2007
26 November 2007 - Results of Annual General Meeting
19 November 2007 - CEO Annual Shareholder’s Presentation
19 November 2007 -Chairman's address 2007 Annual General Meeting
OCTOBER 2007
30 October 2007 - Quarterly report for entities admitted on the basis of commitments
10 October 2007 - Notice of General Meeting
SEPTEMBER 2007
28 September 2007 -
Takeda elects to expand Patrys antibody development collaboration
AUGUST 2007
30 August 2007 - Preliminary Financial Report- Year Ended 30 June 2007
JULY 2007
31 July 2007 - Appendix 4C Quarterly report for entities admitted on the basis of commitments
31 July 2007 - Takeda Advances Collaboration & Completes Additional Investment in Patrys
25 July 2007 - Notice of initial substantial holder
25 July 2007 - Notice of initial substantial holder
12 July 2007 - Notice of initial substantial holder
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
17 July 2007 - Appendix 3X Initial Director’s Interest Notice
13 July 2007 - Successful Listing for Human Antibody Therapeutics Company
13 July 2007 - Option Terms and Conditions
12 July 2007 - Appendix 1A - ASX Listing application and agreement
12 July 2007 - Constitution of Patrys Limited
12 July 2007 - Series 2 Options Terms and conditions of issue
12 July 2007 - PRE-QUOTATION DISCLOSURE
12 July 2007 - ADMISSION TO ASX OFFICIAL LIST AND RELATED DISCOLUSURES
12 July 2007 - COMMENCEMENT OF OFFICIAL
QUOTATION
